There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in ...

Medicare Part D will cover popular weight loss drugs like Wegovy and Ozempic starting in 2026, with copays capped at $50 per ...

The maker of the weight loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of the blockbuster medications.

A new policy shift is reshaping the landscape for GLP-1 drugs, signaling major financial effects for Medicare, insurers, and ...

New research suggests that drugs like Ozempic and Wegovy might trigger more than just a slimmer waistline. Many users have reported digestive issues while taking the medications, including nausea, ...

The Australian Therapeutic Goods Administration (TGA) has updated and aligned safety warnings for people using GLP-1 and dual ...

In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic ...

Ozempic and Wegovy, have lately, become popular weight-loss drugs. Recent research shows how these drugs can work on the brain to control hunger, cravings, and thirst. The findings could help people ...

Usage of GLP-1 medications has increased over the past 18 months, with highest adoption among women and adults aged 50-64, ...

But even as Ozempic enters India, there is a growing sense globally that Novo may have already lost the obesity drug war to ...

A Division Bench of Delhi High Court on Friday declined to stay a Single Judge’s order that had allowed Dr Reddy’s ...

In an interview, Novo Nordisk India’s managing director Vikrant Shrotriya discusses the launch of Ozempic, the company’s ...